Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice. (Immunology, 2010)

(untitled) - Mehta, D; Christmas, R; Waldmann, H; Rosenzweig, M